Your session is about to expire
← Back to Search
Cognitive Bias Modification for Obsessive-Compulsive Disorder
Study Summary
This trial will test whether CBM-I is a feasible and acceptable augmentation to treatment as usual for OCD, and will examine preliminary efficacy by examining clinical outcomes associated with CBM-I.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can use a computer for 20 minutes without a break.I have been diagnosed with a psychotic disorder.I am over 18 years old.I have been diagnosed with OCD and my symptoms are moderate to severe.I am currently experiencing severe symptoms of psychosis.
- Group 1: Cognitive bias modification with treatment as usual
- Group 2: Psychoeducation with treatment as usual
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently any open enrollments for this clinical experiment?
"According to the clinicaltrials.gov website, this study is looking for participants and has been actively recruiting since its initial posting on March 24th 2022. The details of the trial were most recently updated April 7th 2022."
What is the capacity of this research endeavor?
"Affirmative. Information available on clinicaltrials.gov shows that recruitment for this trial is currently in progress and commenced on March 24th 2022. As of April 7th, the medical study has been looking to enrol 106 volunteers from one location."
Share this study with friends
Copy Link
Messenger